After 30 days at room temperature, the medication's potency degrades significantly and it should be discarded
GLP-1 Activity GLP-1 receptor activation is associated with: Reduced appetite and cravings Increased satiety and fullness Slower gastric emptying Blood sugar regulation support GIP Activity GIP receptor activation is being researched for its potential role in: Metabolic regulation Insulin sensitivity support Energy balance Enhanced GLP-1 pathway activity Glucagon Receptor Activity Retatrutide also activates glucagon receptors, which researchers believe may contribute to: Increased energy expenditure Enhanced fat metabolism Greater metabolic activity Additional body composition support Because Retatrutide works across all three pathways simultaneously, many individuals researching it report: Strong appetite suppression Reduced food noise Increased fullness Sustained metabolic support Significant long-term body composition changes Research into triple-agonist peptides remains ongoing, and responses may vary significantly between individuals depending on dosage, consistency, nutrition, lifestyle, stress, sleep, hormonal balance, and overall metabolic health
The World Obesity Federation estimates that, by 2030, adult obesity rates in SA will increase to 37%
Fermented foods and probiotics: the guts new best friend Probiotic-rich foods such as yogurt and kimchi act on gut microbiomes, which modulate GLP-1
